Cre recombinase and other tyrosine recombinases

G Meinke, A Bohm, J Hauber, MT Pisabarro… - Chemical …, 2016 - ACS Publications
Tyrosine-type site-specific recombinases (T-SSRs) have opened new avenues for the
predictable modification of genomes as they enable precise genome editing in heterologous …

Hematopoietic cells from pluripotent stem cells: hope and promise for the treatment of inherited blood disorders

I Rao, L Crisafulli, M Paulis, F Ficara - Cells, 2022 - mdpi.com
Inherited blood disorders comprise a large spectrum of diseases due to germline mutations
in genes with key function in the hematopoietic system; they include immunodeficiencies …

Efficient generation and correction of mutations in human iPS cells utilizing mRNAs of CRISPR base editors and prime editors

D Sürün, A Schneider, J Mircetic, K Neumann… - Genes, 2020 - mdpi.com
In contrast to CRISPR/Cas9 nucleases, CRISPR base editors (BE) and prime editors (PE)
enable predefined nucleotide exchanges in genomic sequences without generating DNA …

Modeling the pathological long-range regulatory effects of human structural variation with patient-specific hiPSCs

M Laugsch, M Bartusel, R Rehimi, H Alirzayeva… - Cell Stem Cell, 2019 - cell.com
The pathological consequences of structural variants disrupting 3D genome organization
can be difficult to elucidate in vivo due to differences in gene dosage sensitivity between …

Targeted repair of CYBB in X-CGD iPSCs requires retention of intronic sequences for expression and functional correction

CL Sweeney, J Zou, U Choi, RK Merling, A Liu… - Molecular Therapy, 2017 - cell.com
X-linked chronic granulomatous disease (X-CGD) is an immune deficiency resulting from
defective production of microbicidal reactive oxygen species (ROS) by phagocytes …

Modeling blood diseases with human induced pluripotent stem cells

M Georgomanoli… - Disease Models & …, 2019 - journals.biologists.com
Induced pluripotent stem cells (iPSCs) are derived from somatic cells through a
reprogramming process, which converts them to a pluripotent state, akin to that of embryonic …

Chronic granulomatous disease

A Rawat, S Bhattad, S Singh - The Indian Journal of Pediatrics, 2016 - Springer
Chronic granulomatous disease (CGD) is the most common symptomatic phagocytic defect.
It is caused by mutations in genes encoding protein subunits of the nicotinamide adenine …

Induced pluripotent stem cells as a tool for modeling hematologic disorders and as a potential source for cell-based therapies

P Pratumkaew, S Issaragrisil, S Luanpitpong - Cells, 2021 - mdpi.com
The breakthrough in human induced pluripotent stem cells (hiPSCs) has revolutionized the
field of biomedical and pharmaceutical research and opened up vast opportunities for drug …

In vitro systems to study inborn errors of immunity using human induced pluripotent stem cells

E Nikolouli, J Reichstein, G Hansen… - Frontiers in …, 2022 - frontiersin.org
In the last two decades, the exponential progress in the field of genetics could reveal the
genetic impact on the onset and progression of several diseases affecting the immune …

Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced …

J Brault, G Vaganay, A Le Roy… - International journal …, 2017 - Taylor & Francis
Chronic granulomatous disease (CGD) is a rare inherited immunodeficiency due to
dysfunction of the phagocytic nicotinamide adenine dinucleotide phosphate (NADPH) …